Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
192,975,286
-
Total 13F shares
-
173,399,113
-
Share change
-
-851,692
-
Total reported value
-
$14,656,072,034
-
Put/Call ratio
-
94%
-
Price per share
-
$84.55
-
Number of holders
-
454
-
Value change
-
+$53,952,753
-
Number of buys
-
235
-
Number of sells
-
173
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q4 2019
As of 31 Dec 2019,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
454 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
173,399,113 shares.
The largest 10 holders included
Capital Research Global Investors, VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., BAKER BROS. ADVISORS LP, JENNISON ASSOCIATES LLC, Clearbridge Investments, LLC, STATE STREET CORP, Dodge & Cox, and AMERIPRISE FINANCIAL INC.
This page lists
455
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.